May 22 Diabetes in COVID-19: Prevalence, Pathophysiology, Prognosis and Practical Considerations
Singh AK, Gupta R, Ghosh A, Misra A
ABSTRACT
Background and objectives:
The high prevalence of diabetes makes it an important comorbidity in patients with COVID-19. We attempted to review and analyze data regarding the association between diabetes and COVID-19, disease pathophysiology in diabetes, and management of patients with diabetes who develop COVID-19 infection.
Methods:
The PubMed and Google Scholar databases were searched using the key terms 'COVID-19', 'SARS-CoV-2', 'diabetes', 'antidiabetic therapy' up to April 2, 2020. full texts of retrieved articles.
Results:
There is evidence of a higher incidence and severity of COVID-19 in patients with diabetes. COVID-19 could have an effect on the pathophysiology of diabetes. Blood glucose monitoring is important not only for patients infected with COVID-19, but also for those without the disease. Innovations like telemedicine are helpful in treating diabetes patients in today's times.